title: [Vitamin D treatment and bone health--Swedish guidelines are needed. Recommendations from the Swedish Society of osteoporosis clinical expert group].
authors.forename: Mattias
authors.initials: M
authors.lastname: Lorentzon
authors.forename: Kristina
authors.initials: K
authors.lastname: Åkesson
authors.forename: Dan
authors.initials: D
authors.lastname: Mellström
authors.forename: Kerstin
authors.initials: K
authors.lastname: Landin-Wilhelmsen
authors.forename: Ylva
authors.initials: Y
authors.lastname: Pernow
authors.forename: Ingrid
authors.initials: I
authors.lastname: Bergström
authors.forename: Östen
authors.initials: Ö
authors.lastname: Ljunggren
mesh_terms: D015519:Bone Density; D002118:Calcium / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D006801:Humans; D010281:Parathyroid Hormone / Q000097:blood; D017410:Practice Guidelines as Topic; D012016:Reference Values; D012307:Risk Factors; D012955:Societies, Medical; D013548:Sweden; D014807:Vitamin D / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000627:therapeutic use; D014808:Vitamin D Deficiency / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D010281:Parathyroid Hormone; D014807:Vitamin D; C104450:25-hydroxyvitamin D; D002118:Calcium